Lymph node dissection declining in SLN-positive melanoma

Pfizer begins trial of COVID drug Paxlovid in kids 6 to 17
9 March 2022
Study finds childhood trauma and genetics linked to increased obesity risk
9 March 2022

Lymph node dissection declining in SLN-positive melanoma

For patients with sentinel lymph node (SLN)-positive melanoma, fewer patients are undergoing completion lymph node dissection (CLND) and more are receiving adjuvant systemic therapy, according to study published online Jan. 27 in the Annals of Surgery.

Comments are closed.